The Relationship of the School Lunch and Other Meals to the Total Adolescent\u27s Nutrient Intake in Logan and Wellsville, Utah

Nutritional problems of var ious population groups throughout the world are constantly being emphasized, It has been pointed out that life expectancy at birth is only thirty to forty years for over half of the world\u27s population , while for those people who have been able to take advantage of modern medical and nutritional science, it is sixty five to seventy years, Hunger, as well as preventing economic advancement, promotes unrest and political upheavals. The United States, in the interest of preserving its own security and way of life has a vital stake in solving world nutritional problems as well as its own. Without doubt, we are all aware of this need today of improving the nutritional needs of our own people in practically all parts of the United States. However, the nutritional needs have to be defined before improvements can be recommended. More exact and reliable criteria are needed for identifying borderline cases of malnutrition for various groups of people. This problem is gradually being solved through correlated medical, biochemical, and dietary studies. Thus, as one of the criteria on which to rely, dietary studies are one of the means of measuring the nutritional adequacy of the diet. An evaluation of the school lunch by means of a dietary study cannot be made without also considering the other foods eaten during the day. The benefit of a good school lunch to health and dietary habits, therefore, may be greatest for those children whose family food supplies and habits are the poorest. The benefit will be greatest in the extent to which the foods provided in the school lunch supplement those supplied in the home. A study of the dietary habits of school children in terms of the nutritive value of the school lunch and the rest of the day\u27s food would help to evaluate the nutritional status for the group studied and measure the effectiveness of the school lunch program for improving the dietary habits of the children. Since the school lunch and its contribution tot the total day\u27s diet had not been studied in Utah, seven-day dietary records of the 8th grade Logan Junior High and 8th and 9th grades Wellsville Junior High students were used in evaluating the nutrient intake of the children. The purpose of this study was to determine the contribution of each meal ( breakfast , noon meal , and evening meal) to the total day\u27s diet with emphasis on children eating school lunch versus the children not eating school lunch . The between-meal foods were also studied to see to what extent this supplementary intake improves the overall adequacy of the adolescent\u27s diet

Harman and Lorandos’ False Critique of Meier et al.’s Family Court Study

Jennifer Harman and Demosthenes Lorandos purport to have identified numerous methodological flaws in our 2019 study of family court outcomes in cases involving abuse and alienation allegations (“FCO study”; Meier et al., 2019). At least half of the supposed flaws they itemized relate to one claim - that they were unable to access our methods and data. They treat the claimed lack of public access as evidence that our study is unreliable, while speculating about other potential flaws. Yet we note - and they acknowledge - that most of the methodological information they sought was in fact available before publication of their article. This article responds to and refutes Harman and Lorandos’ exaggerated and unfounded condemnation of our study. In addition to pointing out that the claimed lack of information would not be a methodological flaw even if true, we explain that their other criticisms are speculative, incorrect, or insignificant. We appreciate this opportunity to clarify that the important findings of the FCO study are valid and should be taken seriously by the courts and those interested in the fairness and safety of custody decisions when there are allegations of abuse and alienation

The trouble with Harman and Lorandos’s attempted refutation of the Meier et al. Family court study

Harman and Lorandos assert that they have produced a study analyzing custody cases involving alienation allegations, which “disconfirms” the findings from our study of family court out- comes in cases involving abuse and alienation. In addition to pointing out the authors’ misrepresentation and mis-reporting of some of their findings, this Response details a series of profound flaws in their study’s design, dataset construction and variable coding, interpretations and analytic approach, as well as a series of statistical errors. The statistical analyses demonstrate that Harman and Lorandos’s five findings of a gender bias in favor of fathers are not supported by their data; the only statistically significant findings that persist after re-analysis of the correct data are consistent with the Meier et al. study. These pervasive design and methodological errors undermine both the appearance and assertion of rigor in their approach; these problems and the foundational differences in their dataset from our own disqualify their study from serving as any kind of credible test or disconfirmation of our study

Boston Hospitality Review: Fall 2016

The Heart of Successful Hotels: Going Beyond the Monopoly Game Strategy By Joseph Khairallah and Andrea Foster -- Fragments of the Past By Peter Szende and Annie Holcombe -- Hospitality Branding in the Age of the Millennial By Allen Adamson and Chekitan S. Dev -- In 2017 What Will a Restaurant Actually Be? A New Taxonomy By Christopher Muller -- The Unreal Thing: Faux Heritage at Disney By Bradford Hudson -- An Insider’s Look at the 2016 Philadelphia Democratic National Convention: Hospitality and Inclusion at Work By Erin Tucker, Leora Halpern Lanz, and Juan Lesme

Child Custody Outcomes in Cases Involving Parental Alienation and Abuse Allegations

Arguably the most troubling aspect of justice system response to intimate partner violence is custody courts\u27 failure to protect children when mothers allege the father is abusive. Family courts\u27 errors in assessing adult and child abuse, and punitive responses to abuse allegations, have been widely documented. A significant contributor to these errors is the pseudo-scientific theory of parental alienation (PA). Originally termed parental alienation syndrome (PAS), the theory suggests that when mothers allege that a child is not safe with the father, they are doing so illegitimately, to alienate the child from the father. PA labeling often results in dismissal of women\u27s and children\u27s reports of abuse, and sometimes trumps even expert child abuse evaluations. PAS was explicitly based on negative stereotypes of mothers and has been widely discredited. The term parental alienation – while treated as distinct - is still widely used in ways that are virtually identical to PAS. Nonetheless, because PA is nominally gender neutral (and not called a scientific syndrome), it continues to have substantial credibility in court. The first goal of this project was to ascertain whether empirical evidence indicates that parental alienation is, like PAS, gender-biased in practice and outcome. Second, the study sought to explore outcomes in custody/abuse litigation by gender and by differing types of abuse. Analysis of over 2000 court opinions confirms that courts are skeptical of mothers’ claims of abuse by fathers; this skepticism is greatest when mothers claim child abuse. The findings also confirm that fathers’ cross-claims of parental alienation increase (virtually doubling) courts’ rejection of mothers’ abuse claims, and mothers’ losses of custody to the father accused of abuse. In comparing court responses when fathers accuse mothers of abuse, a significant gender difference is identified. Finally, the findings indicate that where Guardians Ad Litem or custody evaluators are appointed, unfavorable outcomes for mothers and gender differences are increased. The study relies solely on electronically available published opinions in child custody cases. It has produced an invaluable database identifying 10 years of published cases involving alienation, abuse and custody, while coding parties’ claims and defenses, outcomes, and other key factors by gender and parental status

Boston Hospitality Review: Winter 2019

TABLE OF CONTENTS: "Training: The Necessity of Error Management Training in the Hospitality Industry" by Priyanko Guchait; "Trends: Green Hotels: An Overview" by Minu Agarwal and Prashant Das; "Tourism: Panacea or peril? The implications of Neolocalism as a more intrusive form of tourism" by Makarand Mody and Kyle Koslowsky; "Restaurants: How Can Single-Unit Restaurants Strive for Powerful Online Presence?" by Leora Lanz and Jenna Berry; "Retention: Why Hoteliers Stay and Go: Future Oriented Thinking" by Sean McGinley; "Service Recovery: Failure is Not Fatal: Actionable Insights on Service Failure and Recovery for the Hospitality Industry" by Lisa C. Wan and Elisa Chan; "Research: A Detailed Study of the Expected and Actual Use of Hotel Amenities" by Chekitan S. Dev and Prateek Kumar

Early neurodevelopmental outcome of low birth weight infants surviving neonatal intraventricular hemorrhage

Peer Reviewe

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.

BackgroundAdjuvant chemotherapy for resected early-stage non-small-cell lung cancer (NSCLC) provides a modest survival benefit. Bevacizumab, a monoclonal antibody directed against VEGF, improves outcomes when added to platinum-based chemotherapy in advanced-stage non-squamous NSCLC. We aimed to evaluate the addition of bevacizumab to adjuvant chemotherapy in early-stage resected NSCLC.MethodsWe did an open-label, randomised, phase 3 trial of adult patients (aged ≥18 years) with an Eastern Cooperative Oncology Group performance status of 0 or 1 and who had completely resected stage IB (≥4 cm) to IIIA (defined by the American Joint Committee on Cancer 6th edition) NSCLC. We enrolled patients from across the US National Clinical Trials Network, including patients from the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) affiliates in Europe and from the Canadian Cancer Trials Group, within 6-12 weeks of surgery. The chemotherapy regimen for each patient was selected before randomisation and administered intravenously; it consisted of four 21-day cycles of cisplatin (75 mg/m2 on day 1 in all regimens) in combination with investigator's choice of vinorelbine (30 mg/m2 on days 1 and 8), docetaxel (75 mg/m2 on day 1), gemcitabine (1200 mg/m2 on days 1 and 8), or pemetrexed (500 mg/m2 on day 1). Patients in the bevacizumab group received bevacizumab 15 mg/kg intravenously every 21 days starting with cycle 1 of chemotherapy and continuing for 1 year. We randomly allocated patients (1:1) to group A (chemotherapy alone) or group B (chemotherapy plus bevacizumab), centrally, using permuted blocks sizes and stratified by chemotherapy regimen, stage of disease, histology, and sex. No one was masked to treatment assignment, except the Data Safety and Monitoring Committee. The primary endpoint was overall survival, analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00324805.FindingsBetween June 1, 2007, and Sept 20, 2013, 1501 patients were enrolled and randomly assigned to the two treatment groups: 749 to group A (chemotherapy alone) and 752 to group B (chemotherapy plus bevacizumab). 383 (26%) of 1458 patients (with complete staging information) had stage IB, 636 (44%) had stage II, and 439 (30%) had stage IIIA disease (stage of disease data were missing for 43 patients). Squamous cell histology was reported for 422 (28%) of 1501 patients. All four cisplatin-based chemotherapy regimens were used: 377 (25%) patients received vinorelbine, 343 (23%) received docetaxel, 283 (19%) received gemcitabine, and 497 (33%) received pemetrexed. At a median follow-up of 50·3 months (IQR 32·9-68·0), the estimated median overall survival in group A has not been reached, and in group B was 85·8 months (95% CI 74·9 to not reached); hazard ratio (group B vs group A) 0·99 (95% CI 0·82-1·19; p=0·90). Grade 3-5 toxicities of note (all attributions) that were reported more frequently in group B (the bevacizumab group) than in group A (chemotherapy alone) were overall worst grade (ie, all grade 3-5 toxicities; 496 [67%] of 738 in group A vs 610 [83%] of 735 in group B), hypertension (60 [8%] vs 219 [30%]), and neutropenia (241 [33%] vs 275 [37%]). The number of deaths on treatment did not differ between the groups (15 deaths in group A vs 19 in group B). Of these deaths, three in group A and ten in group B were considered at least possibly related to treatment.InterpretationAddition of bevacizumab to adjuvant chemotherapy did not improve overall survival for patients with surgically resected early-stage NSCLC. Bevacizumab does not have a role in this setting and should not be considered as an adjuvant therapy for patients with resected early-stage NSCLC.FundingNational Cancer Institute of the National Institutes of Health

Muscle expression of human retinol-binding protein (RBP). Suppression of the visual defect of RBP knockout mice.

Mice lacking retinol-binding protein (RBP) have low circulating retinol levels. They have severe visual defects due to a low content of retinol or retinyl esters in the eye. A transgenic mouse strain that expresses human RBP under the control of the muscle creatine kinase promoter in the null background was generated. The exogenous protein bound retinol and transthyretin in the circulation and effectively delivered retinol to the eye. Thus, RBP expressed from an ectopic source suppresses the visual phenotype, and retinoids accumulate in the eye. No human RBP was found in the retinal pigment epithelium of the transgenic mice, indicating that retinol uptake by the eye does not entail endocytosis of the carrier RBP

Freestanding, bendable thin film for supercapacitors using DNA-dispersed double walled carbon nanotubes

This article may be downloaded for personal use only. Any other use requires prior permission of the author and the American Institute of Physics. The following article appeared in APPLIED PHYSICS LETTERS. 95(23):233104 (2009) and may be found at https://doi.org/10.1063/1.3271768 .Freestanding, thin, and bendable electrodes for supercapacitors are fabricated by filtering DNA-dispersed double walled carbon nanotubes (DWNTs) into a thin film and thermally treating the film in argon. We found that DNA has the ability to disperse the strongly bundled DWNTs and is converted to phosphorus-enriched carbons, which give rise to strong redox peaks at around 0.4 V. The combination of the large capacitance from the DNA-derived carbons and the high electrical conductivity of carbon nanotubes allow DWNT/DNA films to be used as a potential electrode material for supercapacitors.ArticleAPPLIED PHYSICS LETTERS. 95(23):233104 (2009)journal articl